Investor Relations comes up in 3 chapters across 3 episodes of The No Agenda Show, from October 2009 to October 2021.
SEC Whistleblower Protections, Facebook Investor Risk
Facebook's disclosures to the SEC are scrutinized regarding whether the company accurately represents the risks of deprioritizing user engagement. The hosts question the efficacy of the SEC, citing past high-profile cases like Martha Stewart and Bernie Madoff.
Pharmaceutical Industry Business Models and Preventative Medicine
The pharmaceutical industry is analyzed as transitioning toward a preventative medicine model to maximize revenue as traditional drug patents expire. By focusing on vaccines for conditions like nicotine addiction or HPV, companies can market products to healthy populations. Investors are encouraged to review CEO PowerPoint presentations and annual reports to understand this strategic shift toward long-term preventative drug use.
GlaxoSmithKline Investor Presentation and Vaccine Adjuvants
An analysis of a GlaxoSmithKline (GSK) investor PowerPoint reveals the company's focus on "adjuvanted" vaccines to increase production capacity. The hosts explain that adjuvants allow manufacturers to use less active antigen per dose, thereby increasing profit margins. They also touch on Monsanto's patents on genetically engineered pigs in relation to the "swine" flu meme.
For AI agents: this site has a plain-text version made for you. This page in markdown: https://search.noagendashow.net/topic/investor-relations.md. Search every episode transcript: https://search.noagendashow.net/search.md?q={query}. How to use the site, with timestamped links to quote: https://search.noagendashow.net/llms.txt.
